Cystex

Quick links to important sections

Cystex

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cystex

Property Description
Active Ingredients Methenamine, Sodium Salicylate, Benzoic Acid
Form Oral Tablet
Pharmacological Class Urinary Anti-infective & Analgesic
Common Purpose Symptomatic relief of urinary discomfort
Origin Synthetic Combination Product

What Type of Medicine is Cystex?

Cystex is categorized as an Over-the-Counter (OTC) combination product, supplied as an oral tablet, which is designed to provide simultaneous support for the urinary system. This medication is officially defined by a dual classification, functioning as both a Urinary Anti-infective and an Analgesic agent due to its components. Its composition is entirely synthetic, positioning it distinctly from treatments containing only a single active ingredient. The proprietary formulation and combination of agents have been clinically recognized for their role in managing minor urinary tract discomfort.

Unlike products that focus solely on immediate pain relief, this combination product utilizes two distinct pharmacological approaches. The formulation is intended to provide broad relief and support for the urinary tract, addressing symptoms of discomfort while working to inhibit bacterial proliferation. This unique positioning is what distinguishes the medication from standard pain relievers or single-agent urinary antiseptics.


What is Cystex Made Of? (Composition and Action)

The Cystex formula is defined by three active ingredients: Methenamine, Sodium Salicylate, and Benzoic Acid. This tripartite composition is the foundation of its dual-action capability. Methenamine acts as the primary antibacterial component, while Sodium Salicylate functions as an Analgesic and a type of NSAID (Nonsteroidal Anti-Inflammatory Drug).

Crucially, Benzoic Acid acts as a necessary urine acidifier, supporting the function of the Methenamine. This synergy positions the medication as an antibiotic-sparing option that works by modifying the urinary environment and providing relief. Methenamine is a urinary antiseptic that is hydrolysed in acidic conditions to release formaldehyde. This confirms that the antibacterial action is dependent on the acidic environment provided by the other ingredients.


What is the General Purpose of Cystex?

The general purpose of Cystex is to provide symptomatic relief for the minor discomforts associated with urinary irritation and offer prophylactic support against bacterial presence in the urinary tract. The preparation specifically targets and relieves symptoms such as painful or burning urination through the action of the analgesic component.

Its comprehensive utility stems directly from its dual-action mechanism: the combination of compounds works to inhibit bacterial growth while simultaneously soothing inflamed or irritated tissue. This strategic combination of actions makes the oral tablet an accessible option for managing general urinary discomfort, such as during the onset of irritation.

Regulatory References

  1. Cystex (Methenamine/Sodium Salicylate) Label - DailyMed

What side effects are possible with Cystex?

Possible Side Effects and Safety Information

The safety profile for Cystex (methenamine and sodium salicylate) is largely defined by the warnings associated with its components, particularly the NSAID, sodium salicylate.


Serious Warnings and Adverse Reactions

Cardiovascular Risk: The product contains an NSAID (sodium salicylate), which may increase the risk of a fatal heart attack or stroke. This risk can occur early in treatment and may be higher in individuals with heart disease or risk factors. It is contraindicated just before or after heart bypass surgery (CABG).

Gastrointestinal Risk: Serious and potentially fatal stomach and intestinal bleeding or ulceration can occur without warning. The risk is higher for those aged 60 or older, those with a history of stomach ulcers or bleeding problems, or those who consume three or more alcoholic drinks daily.

Reye's Syndrome: Due to the salicylate component, children and teenagers who have or are recovering from flu symptoms, fever, or chickenpox should not use this product due to the risk of Reye's syndrome, a rare but serious condition.

Commonly Documented Adverse Reactions:

  • Dysuria (painful urination)
  • Nausea
  • Rash
  • Gastric upset

Safety-Related Restrictions (Contraindications):

This product should not be used by individuals with a known allergy to methenamine, sodium salicylate, or other NSAIDs/aspirin. It is also contraindicated for those with severe renal or hepatic insufficiency, active bleeding gastrointestinal ulcers, or severe asthma associated with nasal polyps. Use of this product is restricted during the last 3 months of pregnancy and in children under 12 years of age without medical guidance.

Monitoring: Patients should stop use and seek immediate medical attention if they experience signs of GI bleeding (vomiting blood, bloody or tarry stools), ringing in the ears (tinnitus), or signs of an allergic reaction (hives, swelling of the face or throat, wheezing).

Overdose and Emergency Response

The official regulatory profile for an overdose of this combination product is primarily defined by the systemic effects of the Sodium Salicylate component. Manifestations of overdose (salicylism) may include early signs such as tinnitus (ringing in the ears), hearing impairment, nausea, vomiting, and abdominal pain. Severe salicylate toxicity can escalate to serious outcomes affecting multiple physiological systems, including metabolic acidosis, hyperthermia, confusion, seizures, and the risk of gastrointestinal bleeding. Overexposure to the Methenamine component may manifest as localized urinary tract signs such as hematuria (blood in the urine).

In the event of an overdose or suspected overdose, the official regulatory instruction is to seek immediate medical attention or contact a Poison Control Center right away. Management procedures described in labeling focus on providing symptomatic and supportive treatment and correcting fluid and electrolyte imbalances. Specific documented interventions may include gastric decontamination measures and alkalinization of the urine to enhance salicylate elimination. No specific antidote is known for the active components.

A critical population-specific regulatory note concerns the risk of Reye’s Syndrome, meaning the product must not be used by children or teenagers recovering from viral illness.

Therapeutic Uses of Cystex

What Cystex Treats: Main Uses and Benefits

Cystex is commonly used in conditions presenting with symptoms related to inflammatory or irritative states of the urinary tract. The combination product is generally applied in settings where supportive symptom management is appropriate. The medication is relevant for easing several distressing manifestations.

It plays a role in managing symptom clusters that may become intense or disruptive, specifically: painful urination, burning sensations, urinary frequency, and urinary urgency. The medication is also applied across domains where additional symptomatic support is needed, assisting patients during episodes of heightened discomfort or when symptoms interfere with daily functioning.

“This medication is commonly used to help with symptoms related to physical discomfort and to support general well-being during symptomatic phases.”

The symptomatic relief may assist with coping more steadily with difficult episodes where symptoms intensify, contributing to easing the overall symptom load in conditions involving episodic manifestations or chronic recurring symptoms.

Quick Fact: Relief for Voiding Discomfort
The product is applicable in conditions marked by increased physiological stress, helping to moderate the disruptive increase in both the frequency and the urgency of urination.

Regulatory References

  1. DailyMed NLM Drug Label

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Cystex — Official Regulatory Information

The following information details the official eligibility and non-eligibility requirements for the use of Cystex (Methenamine and Sodium Salicylate) as stated in regulatory documents.

Contraindicated Populations (Do Not Use)

  • Individuals with known allergy or hypersensitivity to salicylates (including aspirin) or to methenamine.
  • Patients with severe renal impairment or severe hepatic impairment (liver disease), or severe dehydration.
  • Patients with active or recent gastrointestinal bleeding or bleeding gastrointestinal ulcers.
  • Children and teenagers with or recovering from chicken pox or flu-like symptoms, due to the risk of Reye's syndrome.
  • Pregnant individuals, especially during the last three months of pregnancy, unless specifically directed by a physician.

Use Restrictions (Ask a Doctor Before Use)

  • Age: Children under 12 years old, and individuals 60 years or older (due to increased risk of stomach bleeding).
  • Conditions: Individuals with a history of stomach problems (heartburn, ulcers), high blood pressure, heart disease, liver cirrhosis, bleeding problems, kidney disease, or those on a sodium-restricted diet.
  • Physiological State: Individuals who are pregnant or breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory information documents two primary categories of interaction risk associated with the components of Cystex (Methenamine, Sodium Salicylate). The efficacy of the Methenamine component is dependent on maintaining an acidic urinary pH. Therefore, co-administration with strong urine alkalizing agents is formally considered a prohibited interaction as it prevents Methenamine's conversion to its active anti-infective form.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Interacting Substance Category Official Interaction Outcome
Sulfonamide Antibiotics Co-administration is formally contraindicated due to the documented risk of forming insoluble precipitates (crystalluria) in the urine.
Probenecid Documented to reduce the renal clearance of the Salicylate component, leading to increased plasma concentration and potential drug accumulation.
Other NSAIDs and Salicylates Co-administration results in additive pharmacodynamic effects that increase the risk of gastrointestinal mucosal irritation and bleeding.
Alcohol (Ethanol) Consumption is associated with an increased risk of gastrointestinal bleeding due to additive mucosal irritant effects with the Salicylate component.
Alkalinizing Foods/Supplements Can reduce the anti-infective efficacy of Methenamine by interfering with the required acidic urinary environment.

The interaction profile also includes population-specific notes, citing a heightened risk of drug accumulation for the salicylate component in individuals with renal impairment due to reduced clearance, as stated in official regulatory monographs.

Mechanism of Action

Cystex utilizes a dual-component pharmacodynamic mechanism involving methenamine and sodium salicylate. The systemic circulation transports methenamine to the urinary tract where it undergoes hydrolysis in the acidic urine environment, a reaction that yields formaldehyde and ammonia. This conversion is dependent on an acidic urinary pH, which the co-administered sodium salicylate facilitates by contributing to the urinary acidification process. The generated formaldehyde acts as a non-specific bactericidal agent, a mechanism of action that is mediated by the denaturation of bacterial proteins and nucleic acids. This cascade leads to widespread disruption of essential intracellular processes within the target microorganisms, resulting in cell death. Sodium salicylate's physiological consequence extends to the inhibition of the cyclooxygenase (COX) enzyme isoforms, a mechanism common to nonsteroidal anti-inflammatory drugs (NSAIDs). The COX enzyme inhibition downstream reduces the biosynthesis of prostaglandins involved in inflammatory signaling pathways within the urogenital tissues.

Dosage and Administration Information

Cystex is an over-the-counter (OTC) combination product, provided as an oral tablet, with established rules for administration. The primary usage pattern is characterized by a specific dosing frequency, a mandatory fluid intake condition, and a clear time-limit on use.

Official Dosing and Administration Protocol

Feature Guideline
Route of Administration Oral (swallowing the tablet whole)
Standard Dosing Regimen Take 2 tablets per dose
Frequency and Timing 3 times a day (approximately every 8 hours)
Maximum Daily Dose Do not take more than 6 tablets in 24 hours
Fluid Requirement Must be taken with a full glass of water
Use Duration Constraint Do not use for more than a 3 day period unless directed by a doctor

The standard dosage of 2 tablets contains Methenamine 324 mg and Sodium Salicylate 325 mg. This regimen is applicable to adults and children 12 years of age and over. For children under 12 years, administration must be determined by a healthcare professional. A core instruction for use is the requirement to drink plenty of fluids throughout the course of administration, which supports the product's function. The three-day limit establishes the product's role as a short-term, episodic use agent, with continued administration beyond this period requiring professional oversight.

Recent Clinical Evidence

Cystex: Recent Clinical Evidence

Summary of Active Ingredients

Cystex is an over-the-counter (OTC) product designed for temporary relief of lower urinary tract infection (UTI) symptoms, such as burning, urgency, and frequency. Its formula typically contains two active ingredients: Methenamine (an antibacterial agent) and Sodium Salicylate (an analgesic/pain reliever, classified as a non-steroidal anti-inflammatory drug or NSAID).


Evidence for Methenamine

Research on methenamine, the primary component intended to affect bacterial growth, focuses on its function as a urinary antiseptic. Methenamine requires an acidic urine environment to be hydrolyzed (broken down) into formaldehyde, which is a bactericidal agent.

Studies have evaluated methenamine's utility primarily for the prophylaxis (prevention) of recurrent UTIs rather than the treatment of acute, established infections. A systematic review found that methenamine may serve as an antibiotic-sparing option for UTI prevention. Comparative trials have examined methenamine alongside low-dose antibiotics for recurrent UTI, reporting similar reductions in infection rates over a 12-month period.


Role of Sodium Salicylate

Sodium salicylate is included for its analgesic properties to help relieve the pain and discomfort associated with urinary tract irritation, a common symptom reported during UTIs. As an NSAID, it functions to address pain and inflammation.

Safety and Contraindication Notes

The product's efficacy hinges on maintaining an acidic urine pH. Its ingredients mean that it is contraindicated in individuals with known salicylate allergies (including aspirin sensitivity) and is typically avoided in patients with severe renal (kidney) or hepatic (liver) impairment due to the metabolic pathways of the components. The product is not intended to replace prescription antibiotic therapy for definitive treatment of a UTI.

Key Studies & References National Institute for Health and Care Excellence (NICE) Clinical Guideline: Urinary tract infection (lower): antimicrobial prescribing

Frequently Asked Questions (FAQ)

Common questions about Cystex (FAQ)

Q: Can Cystex change the color of my urine?

Official product information notes that, unlike some other urinary relief products, this specific formulation of Cystex is not expected to cause urine discoloration.

Q: Does Cystex contain any dyes or sugar?

The official drug label contains a complete list of inactive ingredients, or excipients, in the product. This list must be consulted to confirm the presence of specific components such as dyes or sugars.

Q: Is it normal to feel a mild stomach upset after taking Cystex?

According to the official product information, mild gastrointestinal upset (stomach upset) and nausea are documented as common adverse reactions. If stomach upset is severe or persists, professional medical attention should be sought.

Q: Why do some people say Cystex is good for preventing UTIs?

The product contains methenamine, which is categorized in regulatory documents as an antibacterial or urinary anti-infective agent. Its function is to slow the growth of certain types of bacteria, which may be why the product is sometimes associated with supportive, preventative use.

Q: What should I do if I accidentally take two doses of Cystex too close together?

In situations where a dose may be taken too close, official guidance usually suggests to skip the potentially extra dose and continue with the original schedule. For all issues related to dosing errors or overdose, professional medical attention should be sought, and a Poison Control Center should be contacted immediately.

Q: Does Cystex have an expiry date, and does it lose potency after a while?

Yes, official regulatory guidance requires products to have an expiration date. To ensure product stability and efficacy, you should only use the medication before its expiration date. Expired product should be disposed of safely.

Q: What are the signs that Cystex is actually starting to work?

Cystex is indicated for the temporary relief of specific lower urinary tract symptoms, such as burning, pain, urgency, and frequency. A reduction in the severity of these discomforts indicates the product is having its intended effect.

Q: Can Cystex cause me to feel dizzy or lightheaded?

Official product warnings state that lightheadedness or dizziness can be signs of a serious side effect. If these symptoms occur, it is necessary to stop use and seek immediate medical attention as directed by the label.

Q: Has Cystex ever been recalled for safety concerns?

Official drug safety and recall information is maintained by regulatory bodies such as the FDA. Patients are advised to check the official FDA databases for the most accurate and up-to-date information regarding product recalls or safety alerts.

Q: Are there any dairy or gluten components in Cystex?

The official product labeling is required to list all inactive ingredients (excipients). Individuals with specific allergen concerns, such as dairy or gluten sensitivities, should carefully review the complete inactive ingredients list on the official drug label.

Q: What is the recommended storage temperature for Cystex tablets?

Regulatory labeling specifies that Cystex should be stored at Controlled Room Temperature, which is defined as 59–86°F (15–30°C). The product must be kept in a cool, dry place and protected from sunlight to maintain its effectiveness.

Q: Will Cystex help with mild back pain associated with a UTI?

The product’s sodium salicylate component functions as a general analgesic (pain reliever). However, the official indications are focused on the temporary relief of lower urinary tract symptoms, such as pain and burning urination.

Q: Are there any long-term side effects associated with Cystex use?

Official regulatory instructions limit the use of Cystex to a maximum of 3 days unless directed otherwise by a doctor. The short duration of use is established due to the safety profile of the NSAID component, which has serious risk warnings for prolonged use, including stomach bleeding and cardiovascular risk.

Q: Does Cystex have a cumulative effect in the body after a few days?

Regulatory documents note that the NSAID component, sodium salicylate, carries a risk of drug accumulation. This risk is specifically highlighted for individuals with conditions like reduced kidney clearance or when taken alongside certain interacting medications.

How should Cystex be stored and disposed of?

How to Store and Dispose of Cystex (Methenamine/Sodium Salicylate Tablets)

The storage and disposal instructions for Cystex tablets are based strictly on official regulatory labeling to maintain product stability and safety.


Storage Requirements

Cystex must be stored at Controlled Room Temperature, which is defined as 59–86°F (15–30°C). The product should be kept in a cool dry place and must be protected from sunlight to preserve its efficacy. For safety, it is a mandatory requirement to Keep out of the reach of children.

Packaging and Disposal

Tablets should only be used if the blister is unopened or undamaged to ensure packaging integrity. Official labeling does not provide specific household disposal instructions for unused or expired tablets. Disposal guidance is limited to the warning to contact a Poison Control Center right away in the event of an overdose.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cystex found in:

A-Z Index: